BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15254771)

  • 1. Substrate specificity of Xenopus matrix metalloproteinase stromelysin-3.
    Amano T; Fu L; Sahu S; Markey M; Shi YB
    Int J Mol Med; 2004 Aug; 14(2):233-9. PubMed ID: 15254771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The matrix metalloproteinase stromelysin-3 cleaves laminin receptor at two distinct sites between the transmembrane domain and laminin binding sequence within the extracellular domain.
    Amano T; Kwak O; Fu L; Marshak A; Shi YB
    Cell Res; 2005 Mar; 15(3):150-9. PubMed ID: 15780176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of matrix metalloproteinases leads to lethality in transgenic Xenopus laevis: implications for tissue-dependent functions of matrix metalloproteinases during late embryonic development.
    Damjanovski S; Amano T; Li Q; Pei D; Shi YB
    Dev Dyn; 2001 May; 221(1):37-47. PubMed ID: 11357192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatial and temporal regulation of collagenases-3, -4, and stromelysin -3 implicates distinct functions in apoptosis and tissue remodeling during frog metamorphosis.
    Damjanovski S; Ishizuya-Oka A; Shi YB
    Cell Res; 1999 Jun; 9(2):91-105. PubMed ID: 10418731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration in vivo that stromelysin-3 functions through its proteolytic activity.
    Noël A; Boulay A; Kebers F; Kannan R; Hajitou A; Calberg-Bacq CM; Basset P; Rio MC; Foidart JM
    Oncogene; 2000 Mar; 19(12):1605-12. PubMed ID: 10734321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatio-temporal regulation and cleavage by matrix metalloproteinase stromelysin-3 implicate a role for laminin receptor in intestinal remodeling during Xenopus laevis metamorphosis.
    Amano T; Fu L; Marshak A; Kwak O; Shi YB
    Dev Dyn; 2005 Sep; 234(1):190-200. PubMed ID: 16059908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid inactivation of alpha-1-proteinase inhibitor by neutrophil specific leukolysin/membrane-type matrix metalloproteinase 6.
    Nie J; Pei D
    Exp Cell Res; 2004 Jun; 296(2):145-50. PubMed ID: 15149845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification of active matrix metalloproteinase catalytic domains and its use for screening of specific stromelysin-3 inhibitors.
    Kannan R; Ruff M; Kochins JG; Manly SP; Stoll I; El Fahime M; Noël A; Foidart JM; Rio MC; Dive V; Basset P
    Protein Expr Purif; 1999 Jun; 16(1):76-83. PubMed ID: 10336863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional activation of the matrix metalloproteinase gene stromelysin-3 coincides with thyroid hormone-induced cell death during frog metamorphosis.
    Patterton D; Hayes WP; Shi YB
    Dev Biol; 1995 Jan; 167(1):252-62. PubMed ID: 7851646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substrate specificity determinants of human macrophage elastase (MMP-12) based on the 1.1 A crystal structure.
    Lang R; Kocourek A; Braun M; Tschesche H; Huber R; Bode W; Maskos K
    J Mol Biol; 2001 Sep; 312(4):731-42. PubMed ID: 11575928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative cleavage sites within the reactive-site loop of native and oxidized alpha1-proteinase inhibitor by selected bacterial proteinases.
    Rapala-Kozik M; Potempa J; Nelson D; Kozik A; Travis J
    Biol Chem; 1999 Oct; 380(10):1211-6. PubMed ID: 10595584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of the stromelysin-3 (MMP-11) catalytic domain complexed with a phosphinic inhibitor mimicking the transition-state.
    Gall AL; Ruff M; Kannan R; Cuniasse P; Yiotakis A; Dive V; Rio MC; Basset P; Moras D
    J Mol Biol; 2001 Mar; 307(2):577-86. PubMed ID: 11254383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High cancer cell death in syngeneic tumors developed in host mice deficient for the stromelysin-3 matrix metalloproteinase.
    Boulay A; Masson R; Chenard MP; El Fahime M; Cassard L; Bellocq JP; Sautès-Fridman C; Basset P; Rio MC
    Cancer Res; 2001 Mar; 61(5):2189-93. PubMed ID: 11280785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational analysis of the cleavage of the cancer-associated laminin receptor by stromelysin-3 reveals the contribution of flanking sequences to site recognition and cleavage efficiency.
    Fiorentino M; Fu L; Shi YB
    Int J Mol Med; 2009 Mar; 23(3):389-97. PubMed ID: 19212658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the S1' subsite glutamine 215 in activity and specificity of stromelysin-3 by site-directed mutagenesis.
    Holtz B; Cuniasse P; Boulay A; Kannan R; Mucha A; Beau F; Basset P; Dive V
    Biochemistry; 1999 Sep; 38(37):12174-9. PubMed ID: 10508422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirement for matrix metalloproteinase stromelysin-3 in cell migration and apoptosis during tissue remodeling in Xenopus laevis.
    Ishizuya-Oka A; Li Q; Amano T; Damjanovski S; Ueda S; Shi YB
    J Cell Biol; 2000 Sep; 150(5):1177-88. PubMed ID: 10974004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A causative role of stromelysin-3 in extracellular matrix remodeling and epithelial apoptosis during intestinal metamorphosis in Xenopus laevis.
    Fu L; Ishizuya-Oka A; Buchholz DR; Amano T; Matsuda H; Shi YB
    J Biol Chem; 2005 Jul; 280(30):27856-65. PubMed ID: 15929979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stromelysin-3 gene expression in human cancer: an overview.
    Rouyer N; Wolf C; Chenard MP; Rio MC; Chambon P; Bellocq JP; Basset P
    Invasion Metastasis; 1994-1995; 14(1-6):269-75. PubMed ID: 7657519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stromelysin-3 is a potent negative regulator of adipogenesis participating to cancer cell-adipocyte interaction/crosstalk at the tumor invasive front.
    Andarawewa KL; Motrescu ER; Chenard MP; Gansmuller A; Stoll I; Tomasetto C; Rio MC
    Cancer Res; 2005 Dec; 65(23):10862-71. PubMed ID: 16322233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human kallikrein 4: enzymatic activity, inhibition, and degradation of extracellular matrix proteins.
    Obiezu CV; Michael IP; Levesque MA; Diamandis EP
    Biol Chem; 2006 Jun; 387(6):749-59. PubMed ID: 16800736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.